ストックスクリーナーアプリを入手
5.975
5.62%
-0.345
前日終値:
$6.32
開ける：
$6.33
24時間の取引高:
1.47M
Relative Volume:
0.91
時価総額：
$573.52M
収益：
-
当期純損益:
$-144.32M
株価収益率:
-2.7408
EPS:
-2.18
ネットキャッシュフロー:
$-105.21M
1週間 パフォーマンス:
-8.79%
1か月 パフォーマンス:
-7.23%
6か月 パフォーマンス:
+42.36%
1年 パフォーマンス:
+25.58%
1日の値動き範囲:
$5.82
$6.33
1週間の範囲:
$5.82
$6.71
52週間の値動き範囲:
$2.25
$7.085
Compass Pathways Plc Adr Stock (CMPS) Company Profile
名前
Compass Pathways Plc Adr
セクター
電話
1-716-676-6461
住所
3RD FLOOR, 1 ASHLEY ROAD, CHESIRE
CMPS を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
CMPS
Compass Pathways Plc Adr
|
5.9778 | 606.35M | 0 | -144.32M | -105.21M | -2.18 |
|
HCA
Hca Healthcare Inc
|
460.45 | 104.90B | 74.37B | 7.31B | 8.10B | 25.88 |
|
THC
Tenet Healthcare Corp
|
199.74 | 18.15B | 20.69B | 2.40B | 1.55B | 15.62 |
|
FMS
Fresenius Medical Care Ag Adr
|
26.43 | 15.75B | 21.23B | 924.30M | 2.22B | 1.2272 |
|
UHS
Universal Health Services Inc
|
219.40 | 13.81B | 16.08B | 1.20B | 1.06B | 17.82 |
|
EHC
Encompass Health Corp
|
115.25 | 11.46B | 5.51B | 494.70M | 386.40M | 4.84 |
Compass Pathways Plc Adr Stock (CMPS) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-06-23 | ダウングレード | Evercore ISI | Outperform → In-line |
| 2025-02-27 | 開始されました | Stifel | Buy |
| 2024-07-23 | 開始されました | RBC Capital Mkts | Outperform |
| 2024-04-01 | 開始されました | Morgan Stanley | Overweight |
| 2023-12-12 | 開始されました | Deutsche Bank | Buy |
| 2022-11-21 | 再開されました | Berenberg | Buy |
| 2022-11-01 | 開始されました | Loop Capital | Buy |
| 2021-10-29 | 開始されました | Oppenheimer | Outperform |
| 2021-07-13 | 開始されました | Citigroup | Buy |
| 2021-06-28 | 開始されました | Maxim Group | Buy |
| 2021-05-11 | 開始されました | Cantor Fitzgerald | Overweight |
| 2021-04-01 | 開始されました | ROTH Capital | Buy |
| 2020-10-14 | 開始されました | H.C. Wainwright | Buy |
| 2020-10-13 | 開始されました | Berenberg | Buy |
| 2020-10-13 | 開始されました | Canaccord Genuity | Buy |
| 2020-10-13 | 開始されました | Cowen | Outperform |
| 2020-10-13 | 開始されました | Evercore ISI | Outperform |
すべてを表示
Compass Pathways Plc Adr (CMPS) 最新ニュース
Sumitomo Mitsui Trust Group Inc. Has $615,000 Stock Holdings in COMPASS Pathways PLC Sponsored ADR $CMPS - Defense World
Compass Pathways Appoints Dr. Jeffrey Jonas to Board of Directors - ANSA
Compass Pathways to Announce Third Quarter Financial Results on November 4, 2025 - Barchart.com
ARK Investment Management LLC Sells 155,582 Shares of COMPASS Pathways PLC Sponsored ADR $CMPS - MarketBeat
Compass Pathways soars 62% after December Fair Value signal - Investing.com
Stableford Capital II LLC Invests $459,000 in COMPASS Pathways PLC Sponsored ADR $CMPS - MarketBeat
COMPASS Pathways (NASDAQ:CMPS) Reaches New 52-Week High After Analyst Upgrade - Defense World
COMPASS Pathways (NASDAQ:CMPS) Price Target Raised to $14.00 at BTIG Research - Defense World
COMPASS Pathways (NASDAQ:CMPS) Sets New 52-Week High After Analyst Upgrade - MarketBeat
COMPASS Pathways (NASDAQ:CMPS) Sets New 12-Month HighWhat's Next? - MarketBeat
Goldman Sachs Group Inc. Sells 81,540 Shares of COMPASS Pathways PLC Sponsored ADR $CMPS - MarketBeat
COMPASS Pathways (NASDAQ:CMPS) Trading 6.4% HigherShould You Buy? - MarketBeat
Brokerages Set COMPASS Pathways PLC Sponsored ADR (NASDAQ:CMPS) PT at $16.29 - MarketBeat
Woodline Partners LP Purchases 1,292,927 Shares of COMPASS Pathways PLC Sponsored ADR $CMPS - MarketBeat
Polar Asset Management Partners Inc. Acquires Shares of 229,806 COMPASS Pathways PLC Sponsored ADR $CMPS - MarketBeat
Vident Advisory LLC Invests $95,000 in COMPASS Pathways PLC Sponsored ADR $CMPS - Defense World
Driehaus Capital Management LLC Invests $2.01 Million in COMPASS Pathways PLC Sponsored ADR $CMPS - MarketBeat
Nantahala Capital Management LLC Purchases 1,829,232 Shares of COMPASS Pathways PLC Sponsored ADR $CMPS - MarketBeat
DAFNA Capital Management LLC Raises Holdings in COMPASS Pathways PLC Sponsored ADR $CMPS - MarketBeat
COMPASS Pathways PLC Sponsored ADR (NASDAQ:CMPS) Receives $16.29 Consensus Target Price from Analysts - Defense World
22NW LP Acquires New Position in COMPASS Pathways PLC Sponsored ADR $CMPS - MarketBeat
CMPS Stock Price and Chart — NASDAQ:CMPS - TradingView
HC Wainwright Issues Negative Outlook for CMPS Earnings - Defense World
Analysts Set COMPASS Pathways PLC Sponsored ADR (NASDAQ:CMPS) Price Target at $17.00 - Defense World
Compass (CMPS) Q2 Loss Improves 27% - The Globe and Mail
Can Compass Pathways Plc ADR Bounce Back? 52-Week Performance and Analyst Predictions - investchronicle.com
Compass Pathways appoints former GW Pharmaceuticals CEO to board - Investing.com India
Compass Pathways appoints former GW Pharmaceuticals CEO to board By Investing.com - Investing.com South Africa
HC Wainwright Lowers Earnings Estimates for COMPASS Pathways - Defense World
Equities Analysts Issue Forecasts for CMPS Q1 Earnings - Defense World
CMPS: Riding the Market Waves of Growth and Decline in 2025 - investchronicle.com
COMPASS Pathways PLC Sponsored ADR (NASDAQ:CMPS) Receives $17.00 Average Target Price from Brokerages - Defense World
WPP (LON:WPP) Stock Price Down 18.8% Following Analyst Downgrade - Defense World
Helen of Troy (NASDAQ:HELE) Hits New 1-Year Low After Earnings Miss - Defense World
Promising Chinese Stocks To Research – July 9th - Defense World
Epiroc AB (publ) (EPOKY) Projected to Post Earnings on Friday - Defense World
COMPASS Pathways (CMPS) Upgraded to Buy: Here's Why - MSN
This Psychedelic Drug Flopped on Trial Results. Should You Buy the Dip? - Barchart.com
Compass’ stock slips despite psilocybin trial hitting target - Clinical Trials Arena
Compass reports positive Phase 3 results for psilocybin depression drug - Investing.com
Compass Pathways Holds Annual General Meeting By Investing.com - Investing.com South Africa
Compass Pathways Holds Annual General Meeting - Investing.com
COMPASS Pathways (CMPS) Upgraded to Buy: Here's What You Should Know - MSN
Market Highlights: Compass Pathways Plc ADR (CMPS) Ends on a Low Note at 4.04 - DWinneX
Compass Pathways appoints new US accounting firm - Investing.com
Compass Pathways stock hits 52-week low at $2.87 - Investing.com
Cantor Fitzgerald maintains Overweight on Compass Pathways stock - Investing.com
Compass Pathways stock hits 52-week low at $3.15 - Investing.com
Earnings call transcript: Compass Pathways Q4 2024 sees stock rise amid stable EPS - Investing.com
Compass Pathways stock hits 52-week low at $3.85 - Investing.com
Compass Pathways' SWOT analysis: psilocybin stock faces trials and trillion-dollar potential - Investing.com
Compass Pathways Plc Adr (CMPS) 財務データ
収益
当期純利益
現金流量
EPS
1.74%
0.77%
大文字化:
|
ボリューム (24 時間):